Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes

Kidney and Blood Pressure Research

Volumn 29, Issue 6, 2007, Pages 338-343

  Ksiazek, Piotr ^a   Buraczynska, Kinga ^a   Buraczynska, Monika ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Diabetes type 2; Genetic polymorphism; Norepinephrine transporter

Indexed keywords

NORADRENALIN TRANSPORTER;

ADULT; AGED; ALLELE; ARTICLE; ELECTROCHEMISTRY; FEMALE; GENE FREQUENCY; GENE SILENCING; GENETIC POLYMORPHISM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC;

EID: 33846420182     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097356     Document Type: Article

References (31)

1. Cavallo-Perin P, Maule S, Quadri R: Sympathetic nervous system, diabetes and hypertension. Clin Exp Hypertens 2001;23:45-55.
2. Mancia G: The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol 2005;42:S17-S25.
3. Wang Y-M, Xu F, Gainetdinov RR, Caron MG: Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene. Biol Psychiatry 1999;46:1124-1130.
4. Blakely RD: Physiological genomics of antidepressant targets: keeping the periphery in mind. J Neurosci 2001;21:8319-8323.
5. Hahn MK, Blakely RD: Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2002;2:217-235.
6. Gainetdinov RR, Caron MG: Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 2003;43:261-284.
7. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P: Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 1981;3:149-156.
8. Bellomo R, Di Giantomasso D: Noradrenaline and the kidney: friends or foes? Crit Care 2001;5:294-298.
9. Lanfranchi A, Spaziani D, Seravalle G, Turri C, Dell'Oro R, Grassi G, Mancia G: Sympathetic control of circulation in hypertension and congestive heart failure. Blood Press 1998;7(suppl 3):40-45.
10. Blakely RD, De Felice LJ, Hartzell C: Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994;196:263-281.
11. - dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 2001;92:21-55.
12. Chen N-H, Reith ME, Quick MW: Synaptic uptake and beyond: the sodium and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 2004;447:519-531.
13. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D: Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-549.
14. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA: A screen of candidate genes and influence of β2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci 2005;120:97-103.
15. Pacholczyk T, Blakely RD, Amara SG;Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350-354.
16. Gelernter J, Kruger S, Pakstis AJ, Pacholczyk T, Sparkes RS, Kidd KK, Amara S: Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16. Genomics 1993;18:690-692.
17. Porzgen P, Bonisch H, Bruss M: Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 1995;215:1145-1150.
18. Stober G, Nothen MM, Porzgen P, Bruss H, Bonisch H, Knapp M, Beckmann H, Propping P: Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996;67:523-532.
19. Madisen L, Hoar LD, Holroyd CD, Crisp M, Hodes ME: DNA banking: the effects of storage of blood and isolated DNA on integrity of DNA. Am J Med Genet 1987;27:379-390.
20. Forster CD, Macdonald IA: The assay of the catecholamine content of small volumes of human plasma. Biomed Chromatogr 1999;13:209-215.
21. Samochowiec J, Kucharska-Mazur J, Kaminski R, Smolka M, Rommelspacher H, Wernicke C, Tymicz A, Schmidt LG: Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 2002;111:229-233.
22. Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J, Hauser J: A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 2002;45:182-185.
23. Owen D, Du L, Bakish D, Lapierre YD, Hrdina PD: Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res 1999;87:1-5.
24. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, Zwanzger P, Schule C, Minov C, Behrens S, Rupprecht R, Hegerl U, Moller HJ, Bondy B: Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002;26:489-493.
25. Esler M, Rumantir M, Kaye D, Lambert G: The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens 2001;14:139S-146S.
26. Salkovic-Petrisic M, Augood SJ, Bicknell RJ: Monoamine transporter gene expression in the central nervous system in diabetes mellitus. J Neurochem 1997;68:2435-2441.
27. Ksiazek P, Wojewoda P, Muc K, Buraczynska M: Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 2003;7:119-123.
28. Goldstein DS: Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983;5:86-89.
29. Esler M, Kaye D: Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev 2000;5:17-25.
30. Backs J, Haunstetter A, Gerber SH: The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. Cardiovasc Res 2005;66:256-264.
31. Hahn MK, Mazei-Robison MS, Blakely RD: Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 2005;68:457-466.